News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,553 Results
Type
Article (88253)
Company Profile (812)
Press Release (785467)
Multimedia
Podcasts (211)
Webinars (32)
Section
Business (233371)
Career Advice (4152)
Deals (39900)
Drug Delivery (160)
Drug Development (91502)
Employer Resources (205)
FDA (18457)
Job Trends (17445)
News (398198)
Policy (40001)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3026)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (169)
Alliances (56982)
ALS (197)
Alzheimer's disease (1847)
Antibody-drug conjugate (ADC) (389)
Approvals (18656)
Artificial intelligence (702)
Autoimmune disease (223)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (486)
Bladder cancer (180)
Brain cancer (71)
Breast cancer (711)
Cancer (5455)
Cardiovascular disease (485)
Career advice (3580)
Career pathing (44)
CAR-T (323)
CDC (68)
Celiac Disease (2)
Cell therapy (892)
Cervical cancer (42)
Clinical research (77598)
Collaboration (2001)
Company closure (6)
Compensation (1271)
Complete response letters (90)
COVID-19 (3009)
CRISPR (110)
C-suite (1002)
Cystic fibrosis (157)
Data (6885)
Decentralized trials (2)
Denatured (78)
Depression (172)
Diabetes (574)
Diagnostics (7364)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (343)
Drug pricing (232)
Drug shortages (36)
Duchenne muscular dystrophy (280)
Earnings (100978)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136102)
Executive appointments (1090)
FDA (21896)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (27)
Funding (1674)
Gene editing (236)
Generative AI (73)
Gene therapy (739)
GLP-1 (1185)
Government (5491)
Grass and pollen (8)
Guidances (392)
Healthcare (20992)
HIV (77)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (313)
Immuno-oncology (81)
Indications (145)
Infectious disease (3342)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (275)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (101)
Layoffs (665)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (26)
Lung cancer (724)
Lymphoma (402)
Machine learning (50)
Management (66)
Manufacturing (968)
MASH (190)
Medical device (15115)
Medtech (15191)
Mergers & acquisitions (23068)
Metabolic disorders (1535)
mRNA (209)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (406)
Neuropsychiatric disorders (112)
Neuroscience (3315)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (72)
Obesity (748)
Opinion (351)
Ovarian cancer (178)
Pain (238)
Pancreatic cancer (257)
Parkinson's disease (339)
Partnered (39)
Patents (562)
Patient recruitment (580)
Peanut (65)
People (67261)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23968)
Phase 2 (33676)
Phase 3 (25365)
Pipeline (6554)
Policy (366)
Postmarket research (3554)
Preclinical (10747)
Press Release (72)
Prostate cancer (282)
Psychedelics (61)
Radiopharmaceuticals (320)
Rare diseases (1062)
Real estate (7445)
Recruiting (81)
Regulatory (29470)
Reports (69)
Research institute (2749)
Resumes & cover letters (653)
Rett syndrome (32)
RNA editing (21)
RSV (92)
Schizophrenia (168)
Series A (283)
Series B (208)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (50)
Startups (4342)
State (2)
Stomach cancer (21)
Supply chain (124)
Tariffs (101)
The Weekly (130)
Vaccines (1202)
Venture capital (104)
Weight loss (511)
Women's health (110)
Worklife (23)
Date
Today (103)
Last 7 days (585)
Last 30 days (3125)
Last 365 days (32837)
2026 (6881)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (95)
Alaska (7)
Arizona (360)
Arkansas (15)
Asia (51751)
Australia (9096)
California (12439)
Canada (3534)
China (1260)
Colorado (526)
Connecticut (548)
Delaware (371)
Europe (119146)
Florida (1854)
Georgia (401)
Hawaii (4)
Idaho (68)
Illinois (1043)
India (83)
Indiana (584)
Iowa (24)
Japan (479)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1546)
Massachusetts (9137)
Michigan (382)
Minnesota (701)
Mississippi (7)
Missouri (150)
Montana (37)
Nebraska (30)
Nevada (138)
New Hampshire (89)
New Jersey (3340)
New Mexico (33)
New York (3276)
North Carolina (1708)
North Dakota (10)
Northern California (6033)
Ohio (382)
Oklahoma (23)
Oregon (54)
Pennsylvania (2478)
Puerto Rico (25)
Rhode Island (53)
South America (1668)
South Carolina (74)
South Dakota (1)
Southern California (4828)
Tennessee (198)
Texas (1968)
United States (44756)
Utah (376)
Vermont (1)
Virginia (316)
Washington D.C. (88)
Washington State (1026)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 874,553 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
AI Drug Discovery Platforms Face New Investor Bar
In a highly competitive space, AI platforms must now prove themselves through proprietary data, focused pipelines and clinical readouts in competitive diseases. Promises of faster, cheaper drug discovery are not enough to entice strong investor engagement.
March 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
March 16, 2026
·
4 min read
Press Releases
Manifold Bio Demonstrates Million-Scale Experimental Validation of AI-Driven Protein Binder Design with NVIDIA
March 16, 2026
·
2 min read
Press Releases
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
March 16, 2026
·
5 min read
Press Releases
Veracyte Names Kevin Haas as Chief Development and Technology Officer
March 16, 2026
·
4 min read
Press Releases
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
March 16, 2026
·
20 min read
Press Releases
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress
March 16, 2026
·
9 min read
Press Releases
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results
March 16, 2026
·
8 min read
Press Releases
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 16, 2026
March 16, 2026
·
3 min read
Press Releases
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
March 16, 2026
·
14 min read
1 of 87,456
Next
